(RYAN) Ryan Specialty Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US78351F1075
Stock: Specialty Insurance, Wholesale Brokerage, Managing Underwriting, Risk Management
Total Rating 17
Risk 69
Buy Signal -0.92
| Risk 5d forecast | |
|---|---|
| Volatility | 41.2% |
| Relative Tail Risk | -7.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.31 |
| Alpha | -47.96 |
| Character TTM | |
|---|---|
| Beta | 0.397 |
| Beta Downside | 0.458 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.72% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Primary Risks
P/E ratio: 85.8511
Description: RYAN Ryan Specialty Holdings January 02, 2026
Ryan Specialty Group Holdings Inc. (NYSE:RYAN) is a Chicago-based wholesale broker and managing underwriter that delivers specialty insurance products and risk-management services to brokers, agents, and carriers across North America, Europe, and Asia-Pacific. Founded in 2010, the firm focuses on commercial, industrial, institutional, and government clients, handling distribution, underwriting, product development, administration, and claims management.
Key metrics from the most recent fiscal year show FY2023 revenue of roughly $1.5 billion, a combined ratio of 92.5 % (indicating underwriting profitability), and a 12 % year-over-year increase in net income driven by growth in cyber-risk and construction-related lines. The specialty broker sector is currently being shaped by rising commercial insurance demand, tighter capacity in traditional markets, and heightened regulatory scrutiny on pricing and reserving practices.
For a deeper quantitative view, you might explore ValueRay’s analytics platform to assess how Ryan’s valuation compares to sector peers.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 86.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: 18.39% < 20% (prev 9.53%; Δ 8.86% < -1%) |
| CFO/TA 0.06 > 3% & CFO 643.7m > Net Income 86.7m |
| Net Debt (3.53b) to EBITDA (805.4m): 4.38 < 3 |
| Current Ratio: 7.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (278.5m) vs 12m ago -4.40% < -2% |
| Gross Margin: 54.62% > 18% (prev 0.40%; Δ 5422 % > 0.5%) |
| Asset Turnover: 30.19% > 50% (prev 26.07%; Δ 4.12% > 0%) |
| Interest Coverage Ratio: 2.33 > 6 (EBITDA TTM 805.4m / Interest Expense TTM 222.4m) |
Altman Z'' 0.75
| A: 0.05 (Total Current Assets 647.3m - Total Current Liabilities 86.2m) / Total Assets 10.56b |
| B: 0.01 (Retained Earnings 120.4m / Total Assets 10.56b) |
| C: 0.05 (EBIT TTM 517.9m / Avg Total Assets 10.11b) |
| D: 0.01 (Book Value of Equity 134.5m / Total Liabilities 9.31b) |
| Altman-Z'' Score: 0.75 = B |
Beneish M -2.61
| DSRI: 1.03 (Receivables 489.0m/389.8m, Revenue 3.05b/2.52b) |
| GMI: 0.73 (GM 54.62% / 39.94%) |
| AQI: 1.90 (AQ_t 0.92 / AQ_t-1 0.48) |
| SGI: 1.21 (Revenue 3.05b / 2.52b) |
| TATA: -0.05 (NI 86.7m - CFO 643.7m) / TA 10.56b) |
| Beneish M-Score: -2.61 (Cap -4..+1) = A |
What is the price of RYAN shares?
As of February 23, 2026, the stock is trading at USD 41.30 with a total of 2,434,077 shares traded.
Over the past week, the price has changed by +4.06%, over one month by -18.06%, over three months by -27.39% and over the past year by -38.27%.
Over the past week, the price has changed by +4.06%, over one month by -18.06%, over three months by -27.39% and over the past year by -38.27%.
Is RYAN a buy, sell or hold?
Ryan Specialty Holdings has received a consensus analysts rating of 3.92.
Therefore, it is recommended to buy RYAN.
- StrongBuy: 4
- Buy: 5
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RYAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.3 | 38.6% |
| Analysts Target Price | 57.3 | 38.6% |
RYAN Fundamental Data Overview February 20, 2026
P/E Trailing = 85.8511
P/E Forward = 16.4474
P/S = 3.5675
P/B = 7.7413
Revenue TTM = 3.05b USD
EBIT TTM = 517.9m USD
EBITDA TTM = 805.4m USD
Long Term Debt = 3.29b USD (from longTermDebt, last quarter)
Short Term Debt = 86.2m USD (from shortTermDebt, last quarter)
Debt = 3.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 14.21b USD (10.68b + Debt 3.68b - CCE 158.3m)
Interest Coverage Ratio = 2.33 (Ebit TTM 517.9m / Interest Expense TTM 222.4m)
EV/FCF = 24.68x (Enterprise Value 14.21b / FCF TTM 575.7m)
FCF Yield = 4.05% (FCF TTM 575.7m / Enterprise Value 14.21b)
FCF Margin = 18.87% (FCF TTM 575.7m / Revenue TTM 3.05b)
Net Margin = 2.84% (Net Income TTM 86.7m / Revenue TTM 3.05b)
Gross Margin = 54.62% ((Revenue TTM 3.05b - Cost of Revenue TTM 1.38b) / Revenue TTM)
Gross Margin QoQ = 90.21% (prev 47.57%)
Tobins Q-Ratio = 1.34 (Enterprise Value 14.21b / Total Assets 10.56b)
Interest Expense / Debt = 1.44% (Interest Expense 53.2m / Debt 3.68b)
Taxrate = 29.97% (13.4m / 44.6m)
NOPAT = 362.7m (EBIT 517.9m * (1 - 29.97%))
Current Ratio = 7.51 (Total Current Assets 647.3m / Total Current Liabilities 86.2m)
Debt / Equity = 5.68 (Debt 3.68b / totalStockholderEquity, last quarter 648.1m)
Debt / EBITDA = 4.38 (Net Debt 3.53b / EBITDA 805.4m)
Debt / FCF = 6.12 (Net Debt 3.53b / FCF TTM 575.7m)
Total Stockholder Equity = 607.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.86% (Net Income 86.7m / Total Assets 10.56b)
RoE = 14.26% (Net Income TTM 86.7m / Total Stockholder Equity 607.8m)
RoCE = 13.28% (EBIT 517.9m / Capital Employed (Equity 607.8m + L.T.Debt 3.29b))
RoIC = 8.88% (NOPAT 362.7m / Invested Capital 4.08b)
WACC = 5.75% (E(10.68b)/V(14.37b) * Re(7.38%) + D(3.68b)/V(14.37b) * Rd(1.44%) * (1-Tc(0.30)))
Discount Rate = 7.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 51.83%
[DCF Debug] Terminal Value 88.06% ; FCFF base≈532.6m ; Y1≈630.3m ; Y5≈975.9m
Fair Price DCF = 192.9 (EV 28.54b - Net Debt 3.53b = Equity 25.01b / Shares 129.7m; r=5.90% [WACC]; 5y FCF grow 19.57% → 2.90% )
EPS Correlation: 73.41 | EPS CAGR: 18.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.01 | Revenue CAGR: 19.36% | SUE: -2.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.46 | Chg30d=-0.014 | Revisions Net=-10 | Analysts=17
EPS current Year (2026-12-31): EPS=2.29 | Chg30d=-0.095 | Revisions Net=-12 | Growth EPS=+16.9% | Growth Revenue=+13.4%
EPS next Year (2027-12-31): EPS=2.72 | Chg30d=-0.122 | Revisions Net=-9 | Growth EPS=+18.7% | Growth Revenue=+14.6%
P/E Forward = 16.4474
P/S = 3.5675
P/B = 7.7413
Revenue TTM = 3.05b USD
EBIT TTM = 517.9m USD
EBITDA TTM = 805.4m USD
Long Term Debt = 3.29b USD (from longTermDebt, last quarter)
Short Term Debt = 86.2m USD (from shortTermDebt, last quarter)
Debt = 3.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 14.21b USD (10.68b + Debt 3.68b - CCE 158.3m)
Interest Coverage Ratio = 2.33 (Ebit TTM 517.9m / Interest Expense TTM 222.4m)
EV/FCF = 24.68x (Enterprise Value 14.21b / FCF TTM 575.7m)
FCF Yield = 4.05% (FCF TTM 575.7m / Enterprise Value 14.21b)
FCF Margin = 18.87% (FCF TTM 575.7m / Revenue TTM 3.05b)
Net Margin = 2.84% (Net Income TTM 86.7m / Revenue TTM 3.05b)
Gross Margin = 54.62% ((Revenue TTM 3.05b - Cost of Revenue TTM 1.38b) / Revenue TTM)
Gross Margin QoQ = 90.21% (prev 47.57%)
Tobins Q-Ratio = 1.34 (Enterprise Value 14.21b / Total Assets 10.56b)
Interest Expense / Debt = 1.44% (Interest Expense 53.2m / Debt 3.68b)
Taxrate = 29.97% (13.4m / 44.6m)
NOPAT = 362.7m (EBIT 517.9m * (1 - 29.97%))
Current Ratio = 7.51 (Total Current Assets 647.3m / Total Current Liabilities 86.2m)
Debt / Equity = 5.68 (Debt 3.68b / totalStockholderEquity, last quarter 648.1m)
Debt / EBITDA = 4.38 (Net Debt 3.53b / EBITDA 805.4m)
Debt / FCF = 6.12 (Net Debt 3.53b / FCF TTM 575.7m)
Total Stockholder Equity = 607.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.86% (Net Income 86.7m / Total Assets 10.56b)
RoE = 14.26% (Net Income TTM 86.7m / Total Stockholder Equity 607.8m)
RoCE = 13.28% (EBIT 517.9m / Capital Employed (Equity 607.8m + L.T.Debt 3.29b))
RoIC = 8.88% (NOPAT 362.7m / Invested Capital 4.08b)
WACC = 5.75% (E(10.68b)/V(14.37b) * Re(7.38%) + D(3.68b)/V(14.37b) * Rd(1.44%) * (1-Tc(0.30)))
Discount Rate = 7.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 51.83%
[DCF Debug] Terminal Value 88.06% ; FCFF base≈532.6m ; Y1≈630.3m ; Y5≈975.9m
Fair Price DCF = 192.9 (EV 28.54b - Net Debt 3.53b = Equity 25.01b / Shares 129.7m; r=5.90% [WACC]; 5y FCF grow 19.57% → 2.90% )
EPS Correlation: 73.41 | EPS CAGR: 18.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.01 | Revenue CAGR: 19.36% | SUE: -2.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.46 | Chg30d=-0.014 | Revisions Net=-10 | Analysts=17
EPS current Year (2026-12-31): EPS=2.29 | Chg30d=-0.095 | Revisions Net=-12 | Growth EPS=+16.9% | Growth Revenue=+13.4%
EPS next Year (2027-12-31): EPS=2.72 | Chg30d=-0.122 | Revisions Net=-9 | Growth EPS=+18.7% | Growth Revenue=+14.6%